You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 558 Programmed death (PD)-1 and PD-ligand-1 inhibitors in the treatment of non-small cell lung cancer: a systematic review of their efficacy and safety

Citation Tools

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Immune-stimulants and immune modulators
558 Programmed death (PD)-1 and PD-ligand-1 inhibitors in the treatment of non-small cell lung cancer: a systematic review of their efficacy and safety

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Lingohr-Smith M, Deitelzweig C, Lin G, et al
558 Programmed death (PD)-1 and PD-ligand-1 inhibitors in the treatment of non-small cell lung cancer: a systematic review of their efficacy and safety
Journal for ImmunoTherapy of Cancer 2020;8:doi: 10.1136/jitc-2020-SITC2020.0558